Indivior Pharmaceuticals, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | $901.0M | $-81.0M | $-44.0M |
| FY2023 | $1.09B | $-152.0M | $-126.0M |
| FY2024 | $1.19B | $38.0M | $7.0M |
| FY2025 | $1.24B | $262.0M | $210.0M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | $901.0M | $-81.0M | $-44.0M |
| FY2023 | $1.09B | $-152.0M | $-126.0M |
| FY2024 | $1.19B | $38.0M | $7.0M |
| FY2025 | $1.24B | $262.0M | $210.0M |